Search

Your search keyword '"MIETTUNEN, PAIVI"' showing total 256 results

Search Constraints

Start Over You searched for: Author "MIETTUNEN, PAIVI" Remove constraint Author: "MIETTUNEN, PAIVI"
256 results on '"MIETTUNEN, PAIVI"'

Search Results

1. Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults

3. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study

4. Relationship of Fatigue, Pain Interference, and Physical Disability in Children Newly Diagnosed With Juvenile Idiopathic Arthritis

5. Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review

6. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry

7. Vertebral body reshaping after fractures: an important index of recovery in glucocorticoid-treated children

8. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

9. Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.

14. Vertebral Body Reshaping after Fractures: An Important Index of Recovery in Glucocorticoid-Treated Children

15. Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis

16. Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort

17. Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy.

20. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort

21. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

23. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

24. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

25. Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis

26. Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

28. Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial

30. Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

31. Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-Treated Rheumatic Disorders

32. Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI Registry.

33. Incident vertebral fractures 12 months following glucocorticoid initiation in children with rheumatic disorders

34. Corticosteroid related changes in body mass index in children and adolescents with rheumatic diseases

35. A154: Glucocorticoid Therapy and the Risk of Incident Vertebral Fracture in Children with Rheumatic Disorders

36. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study

37. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis

39. Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis: Report of Forty-Six Patients From an International Multicenter Series

41. Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty-eight patients

42. Predictors of Early Inactive Disease in a Juvenile Idiopathic Arthritis Cohort: Results of a Canadian Multicenter, Prospective Inception Cohort Study

44. Impact of the COVID-19 pandemic on juvenile idiopathic arthritis presentation and research recruitment: results from the CAPRI registry.

45. Acceptability of an Adolescent Self‐Management Program for Juvenile Idiopathic Arthritis.

46. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Anti-Inflammatory Drugs and/or with Active Spinal Lesions

47. Feasibility and safety of a 6-month exercise program to increase bone and muscle strength in children with juvenile idiopathic arthritis

Catalog

Books, media, physical & digital resources